Do These Coronavirus Vaccine Companies Have a Place in an ESG Portfolio?
Would you want to invest in a company if you knew that it was a major polluter? What about if it underpaid its workers, or didn't communicate transparently with its shareholders? For people who approach their investments strictly through an environmental, social, and governance (ESG) lens, the answer to these questions is a resounding "no."
Nonetheless, it's possible for companies with problematic elements to make products that have extremely positive social impacts. It's also possible to minimize or even eliminate ethically questionable activities. Where does that leave socially conscious investors regarding coronavirus vaccine leaders Pfizer (NYSE: PFE), Moderna (NASDAQ: MRNA), and AstraZeneca (NASDAQ: AZN)?
Image source: Getty Images.
Source Fool.com
